RHUMBLINE ADVISERS

Position in SNN — Smith & Nephew PLC

CIK 1115418 BOSTON, MA

Position in SNN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$370,755

+$110,001 QoQ

Shares Held

12,869

+56.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#135

of 292 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,264,483,794 across 83 Medical Devices names. SNN ranks #58 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	2,820,543	$255,936,071
2	SYK	Stryker Corp	616,745	$194,175,995
3	MDT	Medtronic plc	2,213,044	$173,126,432
4	BSX	Boston Scientific Corp	2,641,843	$112,753,859
5	EW	Edwards Lifesciences Corp	1,096,770	$99,213,814
6	DXCM	Dexcom Inc	768,165	$51,735,912
7	GEHC	GE HealthCare Technologies Inc.	755,006	$48,327,934
8	STE	STERIS plc	217,541	$45,807,608

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$370,755	12,869	+56.8%	Shares	Sole	2026-08-12
2026-03-31	$260,754	8,205	+11.1%	Shares	Sole	2026-05-12
2025-12-31	$242,236	7,383	+6.3%	Shares	Sole	2026-02-13
2025-09-30	$252,034	6,945	-11.5%	Shares	Sole	2025-11-06
2025-06-30	$240,414	7,849	-31.5%	Shares	Sole	2025-08-12
2025-03-31	$325,290	11,466	+1.8%	Shares	Sole	2025-05-29
2024-12-31	$276,770	11,260	+0.4%	Shares	Sole	2025-05-29
2024-09-30	$349,079	11,210	+8.2%	Shares	Sole	2024-11-12
2024-06-30	$256,844	10,365	+8.6%	Shares	Sole	2024-08-01
2024-03-31	$242,086	9,546	+20.8%	Shares	Sole	2024-05-09
2023-12-31	$215,621	7,904	-0.8%	Shares	Sole	2024-02-08
2023-09-30	$197,268	7,964	+0.4%	Shares	Sole	2023-11-09
2023-06-30	$255,710	7,929	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.